Hunan, China
Business Type:
Trading Company
Registered Capital:
510000 USD
Plant Area:
501~1000 square meters
Management System Certification:
ISO 9001
Average Lead Time:
Peak season lead time: within 15 workday
Off season lead time: within 15 workday
OEM/ODM Service
Sample Available

Lenvatinib mesylate, Lenvatinib, Lenvima manufacturer / supplier in China, offering Raw Pharmaceutical powder Lenvatinib mesylate effect on cancer, Injectable Steroid Powder Dehydronandrolon Acetate for Body Building, 99% Purity Raw 99% Powder Oberticholic Acid CAS 459789-99-2 Pharmaceutical Intermediate and so on.

Gold Member Since 2014
Audited Supplier
Supplier Homepage Products Muscle Building Steroids Raw Pharmaceutical powder Lenvatinib mesylate effect on cancer

Raw Pharmaceutical powder Lenvatinib mesylate effect on cancer

Get Latest Price
Min. Order / Reference FOB Price
10 grams US $2.6-7/ grams
Port: Hong Kong, Hong Kong
Production Capacity: 2000kg/Month
Payment Terms: T/T, Western Union, Money Gram, Bitcon
Powder: Yes
Customized: Customized
Certification: ISO 9001, USP, BP
Suitable for: Children, Adult
State: Solid
Purity: >99%

You Might Also Like


Basic Info

Model NO.: CAS No. 857890-39-2
CAS: 857890-39-2
Trade: Lenvima
Character: White powder
MOQ: 10g
Effect: Cancers effect
Package: Discreet package
Package specification: 10g, 100g and kgs
Trademark: ZZYC
Transport Package: Foil Bag or Tin
Specification: 10g/100g/1kg/bag
Origin: China
HS Code: 30043200

Product Description

Raw Pharmaceutical powder Lenvatinib mesylate effect on cancer

Product name: Lenvatinib mesylate
Alias: Lenvatinib mesylate [USAN]; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide mesylate; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7- Methoxy-6-quinolinecarboxamide methanesulfonate; 4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide, methanesulfonic acid; Lenvatinib mesilate (JAN);
CAS number: 857890-39-2
Molecular Formula:C22H23ClN4O7S
Molecular weight: 522.995900
Exact Mass: 522.09800
PSA: 178.32000
LogP: 5.82090

DTC is the most common form of thyroid cancer. It is a cancerous growth of the thyroid. The thyroid is located in the neck and it helps regulate the body's metabolism. The National Cancer Institute predicts that 62.98 million people will be diagnosed with thyroid cancer in 2014 and 1,890 will die of the disease. Lenvima is a kinase inhibitor that acts by blocking certain proteins to help cancer cells grow and differentiate.
"The development of new therapeutic drugs to help people with refractory diseases is a matter of great importance to the FDA," said Pazdur, MD, director of the Office of Metabolism and Oncology Products, FDA Center for Drug Evaluation and Research. "Today's approval provides patients and health care professionals with a new treatment that can help delay the deterioration of DTCs."
Lenvima is completed under the FDA's priority review process. The review of the priority review drug provides an accelerated review. If the drug is approved, it will provide safety and efficacy in the treatment of serious diseases. Obvious improvement.
The drug is also eligible for orphan drug because it aims to treat a rare disease. Lenvima's approval time is approximately 2 months earlier than its target drug applicant's target payment date of April 14, 2015, and April 14, 2015 is the last time the FDA plans to complete the drug review.
The efficacy of Lenvima was based on 392 subjects with invasive, radioiodine-treated DTC who were randomized to Lenvima or placebo. The results of the study showed that the median progression-free survival of subjects treated with Lenvima was 18.3 months, compared with 3.6 months for those treated with placebo.
In addition, 65% of Lenvima-treated subjects had tumor shrinkage compared to only 2% of subjects receiving placebo. Most subjects randomized to placebo were treated with Lenvima after the disease had worsened.
Lenvima Most Common Side Effects
High blood pressure, fatigue, diarrhea, joint muscle pain (joint pain/muscle pain), decreased appetite, vomiting, excessive urine proteinuria (proteinuria), palm swelling and pain, hand and/or sole floor (hand-foot syndrome) , abdominal pain and pronunciation change (voice disorder).
Lenvima can cause serious side effects including heart failure, thrombosis (arterial thromboembolic events), liver damage (liver toxicity), kidney damage (renal failure and injury), perforation of the gastrointestinal tract, or abnormal connection between the stomach or intestines, electrocardiographic activity Changes (prolonged QT interval), hypocalcemia, concomitant headaches, seizures and visual changes (reversible leukoencephalopathy syndrome), severe bleeding (major bleeding), risk of unborn babies if treated during pregnancy, and thyrotropia Hormone production appears to be inhibited. Lenvima is marketed by Eisai, located in New Jersey.

 Our advantages:
Yuancheng is a professional raw powder factory in China for over 10 years, all powders are factory directly supplying.
Our products have exported to Germany, Norway, Poland, Finland, Spain, UK, France, Russia, USA, Australia, Japan, Korea and many other countries, over 100kgs each month.
Professional team special for package and shipment and staring on tracking code 24hours for customs pass guaranteed. 100% pass to UK, Norway, Poland, Spain, USA, Canada, Brazil; 98% pass to Germany, Russia, Australia, New Zealand.
Most of powders are in stock, Chargeable samples are available, Could be shipped out within 24hours.
High quality, good price, fast and safety delivery. Shipment by DHL, TNT, FEDEX, HKEMS, UPS, etc.
Packaging & Delivery:
We have professional team for package and shipment. Special way to ship 10 grams to 100kg powders at one time to your country. Fast and discreet shipment could be arranged for customs pass Guaranteed.
Raw Pharmaceutical powder Lenvatinib mesylate effect on cancer

Commerce clause:

Minimum order quantity10g
Packaging Details1kg/aluminium foil bag or as required
Delivery timeWithin 24 hours after receiving the payment
Supply Ability:200kg/month

Welcome inquiry and trying!
Here is Amy serving. More details,email any time pls!

We also supply:
Raw Pharmaceutical powder Lenvatinib mesylate effect on cancer

Send your message to this supplier

avatar Ms. Amy Yu (, Whatsapp+8618188931013)

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now